valerates has been researched along with Hyperlipoproteinemia Type II in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaukola, S; Mälkönen, M; Manninen, V; Torstila, I; Virtamo, J | 1 |
| Manninen, V | 1 |
| Nash, DT | 1 |
| Berg, K; Børresen, AL; Dahlén, G; Ericson, C; Gillnäs, T | 1 |
| Cramb, R; Hughes, EA; Jones, AF | 1 |
| Houlston, R; Lewis, B; Quiney, J; Watts, GF | 1 |
| Bilheimer, DW; East, C; Grundy, SM | 1 |
| Idzior-Waluś, B; Jamska, B; Malczewska-Malec, M; Nowacki, G; Sznajd, J | 1 |
| Idzior-Waluś, B; Iwanejko, J; Malczewska-Malec, M; Nowacki, G; Sznajd, J | 1 |
| Koskinen, P; Kovanen, PT; Manninen, V | 1 |
| Breslow, JL; Eisenberg, S; Weintraub, MS | 1 |
7 trial(s) available for valerates and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia.
Topics: Adult; Aprotinin; Body Weight; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Kallikreins; Kininogens; Lipids; Lipoproteins, HDL; Male; Middle Aged; Pentanoic Acids; Prekallikrein; Triglycerides; Valerates | 1982 |
Clinical results with gemfibrozil and background to the Helsinki Heart Study.
Topics: Adult; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Follow-Up Studies; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipoproteins, HDL; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates | 1983 |
Effect of gemfibrozil on serum lipid levels.
Topics: Cholesterol; Clinical Trials as Topic; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates; Xylenes | 1980 |
Combination drug therapy for familial combined hyperlipidemia.
Topics: Adult; Cholelithiasis; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pentanoic Acids; Polyamines; Random Allocation; Ultrasonography; Valerates | 1988 |
[Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. I. Changes in lipid levels after treatment (the "net" reduction)].
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Double-Blind Method; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Male; Middle Aged; Pentanoic Acids; Triglycerides; Valerates | 1987 |
[Evaluation of the effectiveness of gemfibrozil in primary dyslipoproteinemias. II. Relation between the results of treatment and type of dyslipoproteinemia].
Topics: Apolipoproteins; Cholesterol; Clinical Trials as Topic; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Pentanoic Acids; Triglycerides; Valerates | 1987 |
A comparison of different formulations and dosage administrations of gemfibrozil.
Topics: Administration, Oral; Adult; Apolipoproteins; Cholesterol, HDL; Cholesterol, LDL; Drug Administration Schedule; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Tablets; Time Factors; Valerates | 1986 |
4 other study(ies) available for valerates and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Gemfibrozil--a new lipid lowering agent.
Topics: Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Double-Blind Method; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Pentanoic Acids; Triglycerides; Valerates; Xylenes | 1980 |
Gemfibrozil plus cholestyramine in familial hypercholesterolaemia.
Topics: Adult; Cholesterol; Cholestyramine Resin; Drug Evaluation; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Pentanoic Acids; Valerates | 1988 |
Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia.
Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Male; Pentanoic Acids; Triglycerides; Valerates | 1988 |
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
Topics: Cholestyramine Resin; Chylomicrons; Dietary Fats; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Lipoproteins; Male; Pentanoic Acids; Triglycerides; Valerates; Vitamin A | 1987 |